TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 8 | 1 | 26 | 18 | 20 | -28 | 7 |
| P | %wins | 100 | 50 | 100 | 100 | 100 | 0 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/9/23 08:00 | 6/8/23 | CRNX | Crinetics Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vivaldi Coelho Rogerio | CA | D | P | 110 | 22.06 | 0 | 5 | New | 5 | D | |||||||||||||||
2/6/15 16:48 | 2/4/15 | ONCE | Spark Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vivaldi Coelho Rogerio | PA | O | Chief Co | P | 58 | 23.00 | 16 | 3 | 64 | 6 | D | -8 | 2 | 3 | 36 | 32 | 31 | -46 | |||||||
7/9/14 19:51 | 7/1/14 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vivaldi Coelho Rogerio | MA | DO | P,CEO | P.d | 250 | 6.00 | 5 | 42 | New | 42 | D | -1 | 13 | -1 | 15 | 3 | 9 | -9 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |